NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO, a registered investment adviser, initiated a new position in Aclaris Therapeutics, Inc. (NASDAQ:ACRS) during Q4 2025, according to its most recent 13F filing with the Securities and Exchange Commission.
The institutional investor purchased 1,899,061 shares of the Healthcare company, valued at approximately $1.3B as of the filing date.
Aclaris Therapeutics, Inc.'s stock currently trades at $3.41 with a market capitalization of $365.1M.